Monday 20 August 2018
Contact US    |    Archive
Channel News Asia
1 months ago

J J beats quarterly expectations on drug sales surge, shares jump

Johnson and Johnson reported a 3.3 percent rise in quarterly profit on Tuesday, as higher sales of cancer drugs Zytiga and Darzalex helped offset pressure on its blockbuster rheumatoid arthritis treatment Remicade.

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

beats

 | 

quarterly

 | 

expectations

 | 

drug

 | 

sales

 | 

surge

 | 

shares

 | 

jump

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)